Delivery Order SPE2DB20D3103-SPE2DB26FL4U3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,569.12 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) on August 6, 2025, with completion targeted for August 7, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform work at its corporate office location in Conshohocken, PA 19428. This...
- The Defense Logistics Agency awarded a $1,097.53 delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) under a firm fixed price contract type. The award, issued on August 5, 2025, with completion targeted for August 6, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply delivery. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,089.54 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension in 7.5mL units. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for ultimate completion on August 13, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply...
- The Defense Logistics Agency awarded a $1,252.44 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL). This non-set-aside contract is scheduled for completion by October 31, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting the federal medical supply chain. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,832.00 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone otic suspension in 7.5 mL units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 19, 2025. The award was issued on August 18, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction within...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,780.32 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5ML) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,244.47 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML on June 18, 2025, with completion scheduled for June 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a small-value pharmaceutical supply transaction...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone otic suspension (7.5ml) valued at $5,275.58 under a firm fixed-price contract. The award, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This contract serves...
- The Defense Logistics Agency awarded a $1,670.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension in 7.5 mL quantities. This is an unset-aside, competitively awarded contract with an ultimate completion date of July 22, 2025. The delivery order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $10,788.64 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, with completion scheduled for September 22, 2025. This contract utilized firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL4U3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,151.50 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone Otic Suspension in 7.5 mL units. This non-competed, firm fixed-price delivery order was awarded on November 3, 2025, with an ultimate completion date of November 4, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a small-value transaction within the company's broader federal medical supply operations. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement valued through December 2026 that provides comprehensive global pharmaceutical support to military healthcare systems. The IDC enables AmerisourceBergen to fulfill federal medical supply requirements across multiple therapeutic domains, including specialty medications, generic drugs, vaccines, and related medical supplies for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 11/3/25 |